We are very happy to announce that BRIC Professor Shawn D. Hingtgen, Ph.D. has received the UCRF Innovation Award! “Our previous work has demonstrated that neural stem cell (NSC)-based therapies could effectively treat Glioblastoma, however limitations in clinically relevant sources NSCs has prevented the advancement of this approach. We proposed to use cutting-edge technology in cellular reprogramming to develop and assess a novel type of NSC derived from fibroblasts. The ultimate goal is to eventually allow the generation of personalized patient-specific NSC-based therapies for treatment of aggressive and deadly Glioblastoma.”